R.H. Bluestein & Co’s Inogen INGN Stock Holding History

R.H. Bluestein & Co’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,003	Closed	-$245K	–	303
2018 Q3	$245K	Buy	+1,003	New	+$232K	0.01%	289

Other funds holding INGN

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

R.H. Bluestein & Co's INGN Position: Q4 2018 in Review

R.H. Bluestein & Co sold out of Inogen (INGN) in Q4 2018, closing a stake of 1,003 shares — an estimated $245K sold.

R.H. Bluestein & Co first reported a position in INGN in Q3 2018 and held it in 1 quarter. The position peaked at $245K in Q3 2018. 271 funds tracked by Wall St. Rank hold INGN as of Q4 2018.

R.H. Bluestein & Co reported no remaining Inogen position as of Q4 2018 after selling out during the quarter.
R.H. Bluestein & Co sold 1,003 Inogen shares in Q4 2018, an estimated $245K.
R.H. Bluestein & Co first reported a position in Inogen in Q3 2018 and held it in 1 quarter.
R.H. Bluestein & Co's Inogen position peaked at $245K in Q3 2018.
271 funds tracked by Wall St. Rank held Inogen as of Q4 2018.

Based on R.H. Bluestein & Co's 13F filing for Q4 2018, filed 13 Feb 2019.